Back
Q2 Holdings Vs. Akero Therapeutics Industry Stock Comparison
Sell
28
QTWO
Q2 Holdings
Last Price:
$80.70
Seasonality Move:
7%
Sell
36
AKRO
Akero Therapeutics
Last Price:
$44.52
Seasonality Move:
-13.74%
Sell
28
Q2 Holdings (QTWO)
is a Sell
Is Q2 Holdings a Buy, Sell or Hold?
-
The current Q2 Holdings [QTWO] share price is $84.10. The Score for QTWO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
QTWO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $45.54. The Score for AKRO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
QTWO Stock Price Chart
What is Q2 Holdings's stock price today?
-
The Q2 Holdings share price today is $84.10Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QTWO is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $45.54The current trend is moderately bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
QTWO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.84 | Sell |
Relative Strength Index (14 RSI): | 34.53 | Sell |
Chaikin Money Flow: | -389193 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (88.17 - 95.89) | Sell |
Bollinger Bands (100): | (85.82 - 103.78) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.17 | Buy |
Relative Strength Index (14 RSI): | 47.8 | Sell |
Chaikin Money Flow: | -840799 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.65 - 56.17) | Sell |
Bollinger Bands (100): | (24.81 - 44.47) | Buy |
QTWO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 87.32 | Sell |
20-day SMA: | 91.08 | Sell |
50-day SMA: | 95.56 | Sell |
200-day SMA: | 81.06 | Buy |
8-day EMA: | 87.17 | Sell |
20-day EMA: | 90.18 | Sell |
50-day EMA: | 93.31 | Sell |
200-day EMA: | 82.02 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.83 | Sell |
20-day SMA: | 51.07 | Sell |
50-day SMA: | 38.61 | Buy |
200-day SMA: | 29.58 | Buy |
8-day EMA: | 48.35 | Sell |
20-day EMA: | 47.71 | Sell |
50-day EMA: | 41.94 | Buy |
200-day EMA: | 32.57 | Buy |
Q2 Holdings Earnings Growth & QTWO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.02 per share, an increase this year of $0.50 per share, and an increase next year of $0.40 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.63 per share.
Q2 Holdings Technical Analysis
Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |